Carcinoma Micromets

Code
APT-CMSP-03AX
Panel
Active-Compendium
88342x1, or 88341x1
Clinical
Pathology
A formalin-fixed, paraffin-embedded (FFPE) tissue block is the preferred specimen type
Block identifiers should be clearly written and match exactly with the specimen ID and specimen labeling as noted on the requisition.
Flag Active
True
Orderable Test Description
Carcinoma micrometastases (micromets) consist of small groups of cancer cells, originating from the original tumor site, that have spread through the lymphovascular system to another part of the body. The presence of metastasis in sentinel lymph nodes (SLN) may be the first indicator that cancer has spread to other sites in the body and is an important prognostic indicator.
Histologic evaluation of lymph nodes using a microscope is the most accurate way to assess for lymph node metastasis, since a significant number of patients have clinically negative lymph nodes. Histologic evaluation involves taking sectioning of the tissue block at three different levels and staining each level with H&E and one of the levels with Pan-Cytokeratin (AE1/AE3) immunohistochemical (IHC) stain. Pan-Cytokeratin is an epithelial cell marker and is used to highlight small tumor cell clusters that may be difficult to detect based on H&E-stain alone.
Orderable Turn Around Time
Tech Only (Stain Only): 1 Day
Meta Description
The carcinoma micromets test helps detect the presence of metastasis in sentinel lymph nodes and is an important prognostic indicator.
Extra Note

Use cold pack for transport, making sure cold pack is not in direct contact with specimen. NYS clients please provide date and time of Collection.

Orderable Biomarkers
NY Approved
True
Orderable Biomarkers JSON
{"Immunohistochemistry (IHC)": {"Expression": ["Pan-Cytokeratin (AE1/AE3)"]}}
Keywords string
Carcinoma micrometastases, Carcinoma micromets, Pan-Cytokeratin Carcinoma Micromets
Title URL
carcinoma-micromets